Balance Sheet Data

Outlook Therapeutics, Inc. (OTLK)

$0.4728

-0.01 (-1.50%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 1.728.0212.5414.4817.40196.97519.681,371.123,617.519,544.34
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 3.612.282.392.203.49128.06337.88891.452,351.986,205.39
Accounts Payable (%)
Capital Expenditure -2.78-0.44-10.26-27.06-71.40-188.37-496.99-1,311.23-3,459.52-9,127.49
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.